Penghua CSI Chinese Medicine ETF(159647) Falls 1.50%, with Latest Price at RMB 0.92

NewTimeSpace (newtimespace.com) News, – As of 13:39 on August 5, 2026, Penghua Traditional Chinese Medicine ETF (159647) fell 1.50%, with its latest price at RMB 0.92. Over a longer horizon, as of August 4, 2026, the ETF had accumulated a gain of 1.97% over the past week, ranking 2nd among 4 comparable funds in terms of gains.

In terms of liquidity, Penghua Traditional Chinese Medicine ETF recorded a turnover rate of 1.68% during the session, with trading volume reaching RMB 23.5846 million. Over a longer period, as of August 4, the ETF’s average daily turnover over the past month was RMB 40.8252 million.

In terms of scale, the ETF’s scale grew by RMB 685 million over the past year, achieving significant growth and ranking 1st among 4 comparable funds in new scale additions. (Data source: Wind)

In terms of units, the ETF’s share count grew by 78.50 million units year‑to‑date, achieving significant growth and ranking 2nd among 4 comparable funds in new share additions. (Data source: Wind)

As of August 4, the net value of Penghua Traditional Chinese Medicine ETF had risen 0.06% over the past 2 years, ranking first among comparable funds. In terms of return capability, as of August 4, 2026, since its inception, the ETF achieved a highest single‑month return of 16.26%, a longest consecutive winning streak of 5 months with a cumulative gain of 20.28%, and an average monthly return of 5.45% during up months. As of August 4, 2026, the ETF’s 3‑month excess annualized return over its benchmark was 7.25%, ranking among the top 2 among 4 comparable funds.

In terms of drawdown, as of August 4, 2026, the ETF’s half‑year drawdown relative to its benchmark was 0.07%, the lowest among comparable funds.

On fees, Penghua Traditional Chinese Medicine ETF charges a management fee of 0.50% and a custody fee of 0.10%, representing the lowest fee structure among comparable funds.

On tracking accuracy, as of August 4, 2026, the ETF’s 1‑year tracking error was 0.045%, the highest tracking precision among comparable funds.

From a valuation perspective, the CSI Traditional Chinese Medicine Index, which the ETF tracks, has a latest price‑to‑earnings (PE‑TTM) ratio of only 22.00x, which is at the 8.34th percentile over the past 3 years, meaning the valuation is lower than for more than 91.66% of the time over the past 3 years, placing it at a historical low.

Penghua Traditional Chinese Medicine ETF closely tracks the CSI Traditional Chinese Medicine Index. The index selects listed company securities whose businesses involve traditional Chinese medicine production and sales as index samples, reflecting the overall performance of listed companies in the traditional Chinese medicine sector.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.